Study S002194

A Pre-Operative Window Study of Tirzepatide in Obesity-Driven Endometrial Cancer

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07065552
Study type: INTERVENTIONAL
Phase: EARLY_PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 20
Start: 2026-04-27
Primary completion: 2028-07
Lead sponsor: UNC Lineberger Comprehensive Cancer Center
Conditions: Endometrial Cancer; Obesity
Interventions: DRUG:Tirzepatide
Results posted: FALSE

Registered primary outcomes

Change in Proliferation [Baseline - Up to 6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.